Posizioni attive di Stella Sarraf
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Spinogenix, Inc.
 Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/01/2016 | - |
| Amministratore Delegato | 01/01/2016 | - | |
| Fondatore | 01/01/2016 | - | |
| Presidente | 01/01/2016 | - | |
Amydis, Inc.
 Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Direttore/Membro del Consiglio | 01/01/2013 | - |
| Amministratore Delegato | 01/01/2013 | - | |
| Fondatore | 01/01/2013 | - |
Storia della carriera di Stella Sarraf
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Settori
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Health Technology |
Amydis, Inc.
Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Commercial Services |
- Borsa valori
- Insiders
- Stella Sarraf
- Esperienza
